Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Dec 24 | ACCD Accolade | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,179 | 0.00 | 39,804 |
2 Dec 24 | ACCD Accolade | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 2,179 | 0.00 | 2,178 |
3 Sep 24 | ACCD Accolade | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,179 | 0.00 | 37,625 |
3 Sep 24 | ACCD Accolade | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 2,179 | 0.00 | 4,357 |
6 Aug 24 | ACCD Accolade | RSU Common Stock | Grant | Acquire A | No | No | 0 | 35,021 | 0.00 | 35,021 |
6 Aug 24 | ACCD Accolade | Common Stock | Option exercise | Acquire M | No | No | 0 | 9,196 | 0.00 | 35,446 |
6 Aug 24 | ACCD Accolade | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 9,196 | 0.00 | 0 |
14 Jun 24 | LYEL Lyell Immunopharma | Option Common Stock | Grant | Acquire A | No | No | 2.36 | 130,000 | 306.80 k | 130,000 |